WuXi Biologics - Depreciation and Amortization Expense

WuXi Biologics's Fiscal Year is From January To December - All Figures are in CNY, Millions.

The item "Depreciation-and-Amortization-Expense" stands at 55.34 Million Chinese Yuans for the trailing twelve months (TTM) period ending 03/31/2020, the lowest value since 03/31/2017.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -62.26 percent compared to the value the year prior.
The 1 year change in percent is -62.26.
The 3 year change in percent is -10.16.
The 5 year change in percent is 3,372.94.

The Serie's long term average value is 67.08 Million Chinese Yuans. It's latest available value, on 03/31/2020, is 17.50 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2016, to it's latest available value, on 03/31/2020, is +8,144.51%.
The Serie's change in percent from it's maximum value, on 06/30/2019, to it's latest available value, on 03/31/2020, is -66.67%.